SEHK:1177Pharmaceuticals
Sino Biopharmaceutical (SEHK:1177) Could Be 66% Below Fair Value As Earnings Lift Interest
Half year earnings update and why Sino Biopharmaceutical stock is in focus
Sino Biopharmaceutical (SEHK:1177) recently reported half year 2026 earnings, with sales of CNY 19,444.36 million and net income of CNY 3,434.6 million. Earnings per share from continuing operations also edged higher versus a year earlier.
See our latest analysis for Sino Biopharmaceutical.
The latest earnings release appears to have sharpened investor focus on Sino Biopharmaceutical, with the stock posting a 3.80% 1...